The purpose of this study is to evaluate the long-term safety and effectiveness of the QDOT Micro system use in conjunction with Visitag Surpoint Module for the treatment of symptomatic drug refractory Paroxysmal Atrial Fibrillation.
Contact phone
517-364-5760
Contact email
[email protected]
Principal investigator
Ali Sheikh, DO
Trial Category
Heart & Vascular
Trial SubCategory
Atrial Fibrillation
Webform